PI3K and MAPK pathway alterations were mutually exclusive: PI3K pathway co-alterations (e.g., PIK3CA and PTEN) occurred in 0.7% of GBM cases, while MAPK mutations (NF1, BRAF, and KRAS) were nearly mutually exclusive. This evidence concerns the gene KRAS and glioblastoma.